Mainz Biomed N.V.

1.07 USD
-0.04 (-3.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mainz Biomed N.V. stock is down -48.31% since 30 days ago. The next earnings date is Sep 6, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 2 November’s closed higher than October. 50% of analysts rate it a buy.

About Mainz Biomed N.V.

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.

  • Cantor Fitzgerald
    Tue Nov 21, 07:47
  • HC Wainwright & Co.
    Mon Nov 20, 06:09